,4 Antibodies blocking PD-L1 or PD-1 inhibit this immunosuppressive pathway and have led to improvements in patient survival in melanoma,5,6 lung cancer,7,8 bladder cancer,9,10 and Merkel cell carcinoma,11,12 among others.2 Here, CD274 is linked to Merkel cell skin cancer.